Dan-Ying Zhang
Overview
Explore the profile of Dan-Ying Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Zhang D, Xie K, Wang C, Xu F
Int Immunopharmacol
. 2024 Dec;
146():113905.
PMID: 39725594
No abstract available.
2.
Liu Z, Lin X, Guo H, Shi X, Zhang D, Sun J, et al.
Int J Biol Sci
. 2024 May;
20(7):2763-2778.
PMID: 38725845
Dysregulation of the aldehyde dehydrogenase (ALDH) family has been implicated in various pathological conditions, including cancer. However, a systematic evaluation of ALDH alterations and their therapeutic relevance in hepatocellular carcinoma...
3.
Li J, Zhang D, Zhu J, Dong L
Cancer Cell Int
. 2024 Jan;
24(1):13.
PMID: 38184573
Gastric cancer remains a leading cause of cancer-related death worldwide, largely due to inadequate screening methods, late diagnosis, and limited treatment options. Liquid biopsy has emerged as a promising non-invasive...
4.
Zhang Z, Xie K, Luo R, Zhang D, He Z, Li K, et al.
Inflammopharmacology
. 2022 Dec;
31(1):423-438.
PMID: 36534240
Objectives: To explore the anti-inflammatory effect and the potential mechanism of dexmedetomidine in ARDS/ALI. Materials And Methods: C57BL/6 mice and EL-4 cells were used in this research. The ALI model...
5.
Lin X, Liu Z, Zhang D, Zhang S, Tang W, Li D, et al.
Exp Hematol Oncol
. 2022 Nov;
11(1):92.
PMID: 36348379
Background: Though circular RNAs (circRNAs) are the key regulators in tumor carcinogenesis, they remain largely unexplored in hepatocellular carcinoma (HCC). Methods: The expression of RanGAP1-derived circRNAs (circ_0063531, circ_0063534, circ_0063513, circ_0063518,...
6.
Liu Z, Zhang D, Lin X, Sun J, Abuduwaili W, Zhang G, et al.
Front Pharmacol
. 2022 Sep;
13:952482.
PMID: 36071851
Sorafenib resistance is often developed and impedes the benefits of clinical therapy in hepatocellular carcinoma (HCC) patients. However, the relationship between sorafenib resistance and tumor immune environment and adjuvant drugs...
7.
Lin X, Zhang D, Liu Z, Tang W, Chen R, Li D, et al.
J Transl Med
. 2022 Aug;
20(1):379.
PMID: 36038907
Background: Hepatocellular carcinoma (HCC) is one of the most malignant tumors to threaten human life, and the survival rate remains low due to delayed diagnosis. Meanwhile, lncRNAs have great potential...
8.
Yang P, Jiang P, Li C, Gao M, Sun Y, Zhang D, et al.
Cell Cycle
. 2021 Oct;
20(22):2402-2412.
PMID: 34606419
Multiple myeloma (MM) remains an incurable hematological malignancy characterized by proliferation and accumulation of plasma cells in the bone marrow. Innovative and effective therapeutic approaches that are able to improve...
9.
Zhang Z, Zhang D, Xie K, Wang C, Xu F
Int Immunopharmacol
. 2021 Jul;
99:107914.
PMID: 34246059
Objectives: Acute respiratory distress syndrome (ARDS) is characterized by an excessive pulmonary inflammatory response. Pyroptosis is a newly form of programmed inflammatory cell death that is triggered by inflammatory caspases....
10.
Zhang D, Zhu L, Liu H, Tseng Y, Weng S, Liu T, et al.
Drug Des Devel Ther
. 2019 Jul;
13:2249-2270.
PMID: 31308634
It is reported that various diseases such as non-alcoholic fatty liver disease (NAFLD) are associated with imbalance of microbiome. And FXR has been well investigated in liver diseases. The objective...